Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Telaprevir for the treatment of hepatitis C.

Forestier N, Zeuzem S.

Expert Opin Pharmacother. 2012 Mar;13(4):593-606. doi: 10.1517/14656566.2012.660524. Epub 2012 Feb 15. Review.

PMID:
22332992
2.

Triple therapy with boceprevir or telaprevir for prior HCV non-responders.

Asselah T.

Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):455-62. doi: 10.1016/j.bpg.2012.09.003.

PMID:
23199504
3.

Telaprevir: a new hope in the treatment of chronic hepatitis C?

Fowell AJ, Nash KL.

Adv Ther. 2010 Aug;27(8):512-22. doi: 10.1007/s12325-010-0047-0. Epub 2010 Jul 21. Review.

PMID:
20652658
4.

[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].

Zuckerman E, Safadi R, Oren R, Shibolet O, Baruch Y, Bruck R, Lurei Y, Kaspa RT, Abu-Mouch S, Shouval D, Ben-Ari Z; Israeli Association for the Study of the Liver..

Harefuah. 2012 Dec;151(12):709-14, 719. Hebrew.

PMID:
23330266
5.

[Direct antiviral treatment strategies in chronic hepatitis C].

Neumann-Haefelin C, Blum HE, Thimme R.

Dtsch Med Wochenschr. 2012 Jun;137(25-26):1360-5. doi: 10.1055/s-0032-1305064. Epub 2012 May 31. Review. German.

PMID:
22653493
6.

[Hepatitis C virus: 25 years-old, the end?].

Pol S.

Med Sci (Paris). 2013 Nov;29(11):998-1003. doi: 10.1051/medsci/20132911016. Epub 2013 Nov 20. Review. French.

7.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
8.

Rapid progression of antiviral treatments of chronic hepatitis C virus infection.

Pol S, Corouge M, Mallet V, Sogni P.

Minerva Gastroenterol Dietol. 2013 Jun;59(2):161-72.

PMID:
23831907
9.

Future perspectives: towards interferon-free regimens for HCV.

Gane E.

Antivir Ther. 2012;17(6 Pt B):1201-10. doi: 10.3851/IMP2431. Epub 2012 Oct 5. Review.

PMID:
23186654
10.

Novel therapeutic approaches for hepatitis C.

Au JS, Pockros PJ.

Clin Pharmacol Ther. 2014 Jan;95(1):78-88. doi: 10.1038/clpt.2013.206. Epub 2013 Oct 14. Review.

PMID:
24126682
11.

Hepatitis C virus: standard-of-care treatment.

Pawlotsky JM.

Adv Pharmacol. 2013;67:169-215. doi: 10.1016/B978-0-12-405880-4.00005-6. Review.

PMID:
23886001
12.

Telaprevir: a hepatitis C NS3/4A protease inhibitor.

Matthews SJ, Lancaster JW.

Clin Ther. 2012 Sep;34(9):1857-82. doi: 10.1016/j.clinthera.2012.07.011. Epub 2012 Aug 28. Review.

PMID:
22951253
13.

Triple therapy with boceprevir or telaprevir for treatment naïve HCV patients.

Esteban R, Buti M.

Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):445-53. doi: 10.1016/j.bpg.2012.09.001. Review.

PMID:
23199503
14.

Therapy of chronic hepatitis C virus infection in HIV co-infected people.

Fabris P, Barnes E, Tositti G, Giordani MT, Grasso A, De Lalla F.

Curr Pharm Des. 2004;10(17):2111-22. Review.

PMID:
15279550
15.

[Chronic hepatitis C infection--eradication of the virus].

Ben Ari Z.

Harefuah. 2014 Jul;153(7):392-3, 433. Hebrew.

PMID:
25189028
16.

Telaprevir for genotype 1 chronic hepatitis C: a systematic review and meta-analysis.

Gu L, Chen Q, Xie J, Yan Y, Wu G, Tan J, Liang B, Chen W, Wu P, Su L, Tang N.

Pharmazie. 2012 Dec;67(12):963-72. Review.

PMID:
23346756
17.

The role of resistance in HCV treatment.

Vermehren J, Sarrazin C.

Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):487-503. doi: 10.1016/j.bpg.2012.09.011. Review.

PMID:
23199507
18.

Telaprevir user's guide.

Liapakis A, Jacobson I.

Clin Liver Dis. 2011 Aug;15(3):555-71. doi: 10.1016/j.cld.2011.05.013. Review.

PMID:
21867936
19.

Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infection.

Gentile I, Viola C, Borgia F, Castaldo G, Borgia G.

Curr Med Chem. 2009;16(9):1115-21. Review.

PMID:
19275615
20.

Future of hepatitis C therapy: development of direct-acting antivirals.

Dore GJ, Matthews GV, Rockstroh J.

Curr Opin HIV AIDS. 2011 Nov;6(6):508-13. doi: 10.1097/COH.0b013e32834b87f8. Review.

PMID:
21897228

Supplemental Content

Support Center